Show simple item record

dc.contributor.authorMarbán Castro, Elena
dc.contributor.authorPons Durán, Clara
dc.contributor.authorGracía Otero, Laura
dc.contributor.authorChen, Haily
dc.contributor.authorBernardo Herrera, Luis
dc.contributor.authorGil Mira, María del Mar 
dc.contributor.authorGoncé, Anna
dc.contributor.authorFerriols Pérez, Elena
dc.contributor.authorRodríguez, Miguel Ángel
dc.contributor.authorToro, Paloma
dc.contributor.authorBardají, Azucena
dc.contributor.authorGonzález, Raquel
dc.contributor.authorMenéndez, Clara
dc.contributor.authorEnguita Fernández, Cristina
dc.date.accessioned2022-01-10T12:36:20Z
dc.date.available2022-01-10T12:36:20Z
dc.date.issued2021
dc.identifier.issn1660-4601spa
dc.identifier.urihttp://hdl.handle.net/10641/2631
dc.description.abstractParticipation of pregnant women in clinical trials entails challenges mainly related to concerns about the risks for fetuses. We undertook a qualitative study from June to October 2020 to assess the acceptability of participating in COVID-19 clinical trials among pregnant women in Spain. Phenomenology and grounded theory were used as methodological approaches. Semi-structured interviews were conducted with 24 pregnant women and six healthcare providers. Women were unsure if pregnancy was a risk factor to acquire the infection or to develop severe disease and expressed the limited information they had received, which led to uncertainties and emotional suffering. They had concerns regarding participation in clinical trials on COVID-19, regardless of the drug under study. Healthcare providers alluded to the importance of involving pregnant women’s relatives at the recruitment visit of the clinical trial. These findings may be useful to facilitate pregnant women’s participation in clinical trials.spa
dc.language.isoengspa
dc.publisherInternational Journal of Environmental Research and Public Healthspa
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectCOVID-19spa
dc.subjectPregnancyspa
dc.subjectClinical trialspa
dc.subjectHealthcare professionalsspa
dc.titleAcceptability of Clinical Trials on COVID-19 during Pregnancy among Pregnant Women and Healthcare Providers: A Qualitative Study.spa
dc.typearticlespa
dc.description.versionpost-printspa
dc.rights.accessRightsopenAccessspa
dc.description.extent599 KBspa
dc.identifier.doi10.3390/ijerph182010717spa
dc.relation.publisherversionhttps://www.mdpi.com/1660-4601/18/20/10717spa


Files in this item

FilesSizeFormatView
2.- Acceptability of clinical ...598.7KbPDFView/Open

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 3.0 España
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 España